Found: 19
Select item for more details and to access through your institution.
Heparin Dosing Regimen Optimization in Veno-Arterial Extracorporeal Membrane Oxygenation: A Pharmacokinetic Analysis.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 6, p. 770, doi. 10.3390/pharmaceutics16060770
- By:
- Publication type:
- Article
Relationship between plasma tissue Factor Pathway Inhibitor (TFPI) levels, thrombin generation and clinical risk of bleeding in patients with severe haemophilia A or B.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 693, doi. 10.1111/hae.15020
- By:
- Publication type:
- Article
ABO Blood Groups in Systemic Sclerosis: Distribution and Association with This Disease's Characteristics.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 1, p. 148, doi. 10.3390/jcm12010148
- By:
- Publication type:
- Article
Derivation and Validation of a Predictive Score for Respiratory Failure Worsening Leading to Secondary Intubation in COVID-19: The CERES Score.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 8, p. 2172, doi. 10.3390/jcm11082172
- By:
- Publication type:
- Article
Impact of aPTT reagents on measurement of a PEGylated recombinant FVIII (Adynovi<sup>®</sup>/Adynovate<sup>®</sup>): A French multicentric field assay study.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
The homozygous variant p.Gln1311* in exon 28 of VWF is associated with the development of alloantibodies in 3 unrelated patients with type 3 VWD.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e491, doi. 10.1111/hae.14207
- By:
- Publication type:
- Article
Acquired Hemophilia A in IgG4-Related Disease: Case Report, Immunopathogenic Study, and Review of the Literature.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.558811
- By:
- Publication type:
- Article
Emicizumab treatment: Impact on coagulation tests and biological monitoring of haemostasis according to clinical situations (BIMHO group proposals).
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 6, p. 675, doi. 10.1111/ejh.13490
- By:
- Publication type:
- Article
Factor VIII and IX assays for post‐infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT).
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 103, doi. 10.1111/ejh.13423
- By:
- Publication type:
- Article
Multicentre pharmacokinetic evaluation of rFVIII‐Fc (efmoroctocog alfa) in a real life and comparison with non‐extended half‐life FVIII concentrates.
- Published in:
- Haemophilia, 2020, v. 26, n. 2, p. 282, doi. 10.1111/hae.13946
- By:
- Publication type:
- Article
Assessment of primary haemostasis with a new recombinant von Willebrand factor in patients with von Willebrand disease.
- Published in:
- Haemophilia, 2020, v. 26, n. 2, p. e44, doi. 10.1111/hae.13916
- By:
- Publication type:
- Article
Dosage de l'activité du facteur IX chez les patients hémophiles B substitués.
- Published in:
- Hematologie, 2020, v. 26, n. 1, p. 18, doi. 10.1684/hma.2019.1491
- By:
- Publication type:
- Article
Risk of Pulmonary Embolism More Than 6 Weeks After Surgery Among Cancer-Free Middle-aged Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Dosage de l'activité du facteur VIII chez les patients hémophiles A substitués.
- Published in:
- Hematologie, 2019, v. 25, n. 6, p. 298, doi. 10.1684/hma.2019.1492
- By:
- Publication type:
- Article
Multicentre evaluation of CK Prest<sup>®</sup> for assaying plasma levels of factor IX fused with albumin (Idelvion<sup>®</sup>).
- Published in:
- Haemophilia, 2019, v. 25, n. 5, p. e327, doi. 10.1111/hae.13812
- By:
- Publication type:
- Article
Dosage de l'activité du facteur IX chez les patients hémophiles B substitués.
- Published in:
- Annales de Biologie Clinique, 2019, v. 77, n. 1, p. 41, doi. 10.1684/abc.2019.1414
- By:
- Publication type:
- Article
Dosage de l'activité du facteur VIII chez les patients hémophiles A substitués.
- Published in:
- Annales de Biologie Clinique, 2019, v. 77, n. 1, p. 53, doi. 10.1684/abc.2019.1413
- By:
- Publication type:
- Article
Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article